Free Trial

Delcath Systems (DCTH) Financials

Delcath Systems logo
$10.30 -0.23 (-2.18%)
As of 11:15 AM Eastern
Annual Income Statements for Delcath Systems

Annual Income Statements for Delcath Systems

This table shows Delcath Systems' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders
-37 -48 -26
Consolidated Net Income / (Loss)
-37 -48 -26
Net Income / (Loss) Continuing Operations
-37 -48 -26
Total Pre-Tax Income
-37 -48 -26
Total Operating Income
-34 -38 -12
Total Gross Profit
2.03 1.43 31
Total Revenue
2.72 2.07 37
Operating Revenue
2.72 2.07 37
Total Cost of Revenue
0.69 0.64 6.19
Operating Cost of Revenue
0.69 0.64 6.19
Total Operating Expenses
36 40 43
Selling, General & Admin Expense
17 22 30
Research & Development Expense
19 18 14
Total Other Income / (Expense), net
-2.69 -9.44 -14
Interest & Investment Income
-2.69 -1.44 0.13
Other Income / (Expense), net
0.00 -8.00 -14
Other Gains / (Losses), net
0.03 -0.06 -0.03
Basic Earnings per Share
($4.12) ($2.94) ($0.93)
Weighted Average Basic Shares Outstanding
8.86M 16.23M 28.51M
Diluted Earnings per Share
($4.12) ($2.94) ($0.93)
Weighted Average Diluted Shares Outstanding
8.86M 16.23M 28.51M
Weighted Average Basic & Diluted Shares Outstanding
10.06M 24.56M 33.40M

Quarterly Income Statements for Delcath Systems

This table shows Delcath Systems' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders
-8.88 -8.47 -9.00 -7.20 -20 -11 -11 -14 1.86 -3.40
Consolidated Net Income / (Loss)
-8.88 -8.47 -9.00 -7.20 -20 -11 -11 -14 1.86 -3.40
Net Income / (Loss) Continuing Operations
-8.88 -8.47 -9.00 -7.20 -20 -11 -11 -14 1.86 -3.40
Total Pre-Tax Income
-8.90 -8.48 -9.01 -7.21 -20 -11 -11 -14 1.83 -3.35
Total Operating Income
-8.17 -7.85 -8.33 -8.00 -11 -11 -10 -3.91 -1.26 3.04
Total Gross Profit
0.67 0.40 0.42 0.35 0.30 0.37 2.24 6.25 9.56 13
Total Revenue
0.91 0.64 0.60 0.50 0.43 0.54 3.14 7.77 11 15
Operating Revenue
0.91 0.64 0.60 0.50 0.43 0.54 3.14 7.77 11 15
Total Cost of Revenue
0.24 0.24 0.18 0.15 0.13 0.17 0.90 1.52 1.64 2.13
Operating Cost of Revenue
0.24 0.24 0.18 0.15 0.13 0.17 0.90 1.52 1.64 2.13
Total Operating Expenses
8.84 8.25 8.74 8.34 11 12 13 10 11 9.94
Selling, General & Admin Expense
4.78 3.82 4.17 4.79 6.20 6.96 8.81 6.77 6.95 7.02
Research & Development Expense
4.07 4.43 4.58 3.56 4.66 4.71 3.70 3.39 3.87 2.91
Total Other Income / (Expense), net
-0.73 -0.63 -0.69 0.79 -9.78 0.24 -0.81 -9.84 3.09 -6.38
Interest & Investment Income
-0.73 -0.65 -0.69 -0.37 -0.40 0.02 -0.20 -0.08 0.11 0.30
Other Income / (Expense), net
0.00 0.02 0.00 1.16 -9.38 0.23 -0.61 -9.76 2.98 -6.68
Other Gains / (Losses), net
0.03 - 0.01 0.01 -0.01 -0.07 -0.02 0.01 0.04 -0.05
Basic Earnings per Share
($0.96) ($0.82) ($0.77) ($0.58) ($1.14) ($0.45) ($0.45) ($0.48) $0.06 ($0.06)
Weighted Average Basic Shares Outstanding
9.22M 8.86M 11.62M 12.46M 17.86M 16.23M 24.89M 28.36M 28.74M 28.51M
Diluted Earnings per Share
($0.96) ($0.82) ($0.77) ($0.58) ($1.14) ($0.45) ($0.45) ($0.48) $0.06 ($0.06)
Weighted Average Diluted Shares Outstanding
9.22M 8.86M 11.62M 12.46M 17.86M 16.23M 24.89M 28.36M 32.35M 28.51M
Weighted Average Basic & Diluted Shares Outstanding
8.60M 10.06M 10.62M 15.28M 22.05M 24.56M 27.79M 28.00M 31.97M 33.40M

Annual Cash Flow Statements for Delcath Systems

This table details how cash moves in and out of Delcath Systems' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents
-15 0.87 20
Net Cash From Operating Activities
-25 -31 -19
Net Cash From Continuing Operating Activities
-25 -31 -19
Net Income / (Loss) Continuing Operations
-37 -48 -26
Consolidated Net Income / (Loss)
-37 -48 -26
Depreciation Expense
0.13 0.13 0.13
Amortization Expense
0.77 0.90 -0.03
Non-Cash Adjustments To Reconcile Net Income
8.54 16 23
Changes in Operating Assets and Liabilities, net
2.11 -0.91 -16
Net Cash From Investing Activities
-0.21 -20 -0.98
Net Cash From Continuing Investing Activities
-0.21 -20 -0.98
Purchase of Property, Plant & Equipment
-0.21 -0.06 -0.56
Purchase of Investments
0.00 -20 -52
Sale and/or Maturity of Investments
0.00 0.00 52
Net Cash From Financing Activities
10 52 39
Net Cash From Continuing Financing Activities
10 52 39
Repayment of Debt
-0.71 -6.31 -11
Issuance of Common Equity
11 23 7.02
Other Financing Activities, net
0.00 35 43
Other Net Changes in Cash
-0.12 0.06 -0.03
Cash Interest Paid
1.87 1.46 1.24

Quarterly Cash Flow Statements for Delcath Systems

This table details how cash moves in and out of Delcath Systems' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Net Change in Cash & Equivalents
-0.37 -2.16 12 -9.68 26 -28 -0.89 2.97 -6.47 24
Net Cash From Operating Activities
-5.18 -7.36 -4.26 -9.65 -9.16 -8.18 -9.58 -4.45 -3.64 -1.01
Net Cash From Continuing Operating Activities
-5.18 -7.36 -4.26 -9.65 -9.34 -8.00 -9.58 -4.45 -3.70 -0.94
Net Income / (Loss) Continuing Operations
-8.88 -8.47 -9.00 -7.20 -20 -11 -11 -14 1.86 -3.40
Consolidated Net Income / (Loss)
-8.88 -8.47 -9.00 -7.20 -20 -11 -11 -14 1.86 -3.40
Depreciation Expense
0.07 0.03 0.03 0.03 0.03 0.04 0.03 0.03 0.03 0.04
Amortization Expense
0.53 -0.15 0.19 0.19 0.19 0.31 0.03 0.04 -0.06 -0.04
Non-Cash Adjustments To Reconcile Net Income
1.43 2.41 1.79 0.65 12 1.73 3.61 13 -0.83 7.46
Changes in Operating Assets and Liabilities, net
1.67 -1.18 2.72 -3.32 -1.36 1.05 -2.14 -3.67 -4.71 -5.00
Net Cash From Investing Activities
-0.07 - 0.00 -0.04 0.00 -20 4.66 10 -0.70 -15
Net Cash From Continuing Investing Activities
-0.07 - 0.00 -0.04 0.00 -20 4.66 10 -0.70 -15
Purchase of Property, Plant & Equipment
-0.07 - 0.00 -0.04 0.00 -0.02 -0.01 -0.10 -0.22 -0.23
Purchase of Investments
- - 0.00 - - -20 -10 -10 -11 -21
Sale and/or Maturity of Investments
- - 0.00 - - - 15 21 11 5.69
Net Cash From Financing Activities
4.90 5.25 17 0.01 35 0.00 4.02 -2.85 -2.14 40
Net Cash From Continuing Financing Activities
4.90 5.25 17 0.01 35 0.00 4.02 -2.85 -2.14 40
Repayment of Debt
- -0.71 -6.31 - - - -3.05 -3.05 -2.50 -2.00
Other Financing Activities, net
- - 0.00 0.01 35 0.00 0.00 0.43 0.19 42
Other Net Changes in Cash
-0.02 -0.05 0.02 -0.00 0.01 0.03 0.02 -0.01 0.01 -0.05
Cash Interest Paid
0.50 0.54 0.49 0.30 0.34 0.34 0.25 0.13 0.01 0.85

Annual Balance Sheets for Delcath Systems

This table presents Delcath Systems' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Total Assets
18 39 77
Total Current Assets
16 37 74
Cash & Equivalents
7.67 13 32
Restricted Cash
4.15 0.05 0.00
Short-Term Investments
0.00 20 21
Accounts Receivable
0.37 0.24 11
Inventories, net
2.00 3.32 6.93
Prepaid Expenses
1.97 1.09 2.70
Plant, Property, & Equipment, net
1.42 1.35 1.79
Total Noncurrent Assets
0.29 0.10 1.04
Other Noncurrent Operating Assets
0.29 0.10 1.04
Total Liabilities & Shareholders' Equity
18 39 77
Total Liabilities
24 23 7.84
Total Current Liabilities
15 16 6.14
Short-Term Debt
7.85 10 0.00
Accounts Payable
2.02 1.01 0.96
Accrued Expenses
4.69 5.25 5.08
Other Current Liabilities
0.19 0.04 0.11
Total Noncurrent Liabilities
8.99 6.39 1.70
Other Noncurrent Operating Liabilities
1.14 6.39 1.70
Commitments & Contingencies
0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-5.86 16 69
Total Preferred & Common Equity
-5.86 16 69
Preferred Stock
0.00 0.00 0.00
Total Common Equity
-5.86 16 69
Common Stock
452 521 600
Retained Earnings
-457 -505 -532
Accumulated Other Comprehensive Income / (Loss)
-0.08 0.14 0.08

Quarterly Balance Sheets for Delcath Systems

This table presents Delcath Systems' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024
Total Assets
20 31 21 48 36 34 32
Total Current Assets
18 29 19 46 34 31 29
Cash & Equivalents
9.83 24 15 40 12 15 8.32
Restricted Cash
4.15 0.05 0.05 0.05 0.05 0.00 0.00
Short-Term Investments
- - - - 15 5.12 5.68
Accounts Receivable
0.54 0.46 0.13 0.21 1.56 3.73 6.94
Inventories, net
1.93 2.34 2.48 2.67 3.63 6.32 6.64
Prepaid Expenses
2.04 1.96 2.28 2.71 1.28 1.45 1.31
Plant, Property, & Equipment, net
1.45 1.39 1.40 1.37 1.34 1.42 1.73
Total Noncurrent Assets
0.29 0.19 0.18 0.11 1.12 1.09 1.07
Other Noncurrent Operating Assets
0.29 0.19 0.18 0.11 1.12 1.09 1.07
Total Liabilities & Shareholders' Equity
20 31 21 48 36 34 32
Total Liabilities
25 25 21 23 21 30 23
Total Current Liabilities
14 13 11 14 13 12 22
Short-Term Debt
6.48 3.77 4.51 7.96 7.36 4.49 2.00
Accounts Payable
2.63 2.43 0.97 0.75 1.49 3.28 0.94
Accrued Expenses
5.14 7.12 5.55 5.23 4.40 4.42 5.71
Other Current Liabilities
0.20 0.09 0.09 0.04 0.10 0.10 13
Total Noncurrent Liabilities
11 12 10 8.88 8.14 17 1.53
Other Noncurrent Operating Liabilities
1.30 6.10 4.93 6.88 8.14 17 1.53
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-5.25 -13 -0.24 25 15 4.19 8.57
Total Preferred & Common Equity
-5.25 -13 -0.24 25 15 4.19 8.57
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
-5.25 -13 -0.24 25 15 4.19 8.57
Common Stock
442 453 474 519 531 534 537
Retained Earnings
-447 -466 -474 -494 -516 -530 -528
Accumulated Other Comprehensive Income / (Loss)
-0.06 -0.06 -0.06 -0.06 0.16 0.01 0.01

Annual Metrics And Ratios for Delcath Systems

This table displays calculated financial ratios and metrics derived from Delcath Systems' official financial filings.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Growth Metrics
- - -
Revenue Growth
-23.52% -24.05% 1,701.69%
EBITDA Growth
-37.34% -37.03% 41.58%
EBIT Growth
-38.38% -36.41% 42.66%
NOPAT Growth
-38.00% -12.79% 67.50%
Net Income Growth
-42.34% -30.60% 44.66%
EPS Growth
-14.76% 28.64% 68.37%
Operating Cash Flow Growth
-10.38% -25.25% 40.22%
Free Cash Flow Firm Growth
6.26% -5.08% -38.99%
Invested Capital Growth
-415.85% -230.01% 335.87%
Revenue Q/Q Growth
-35.11% -4.57% 64.30%
EBITDA Q/Q Growth
-12.02% -6.54% 21.79%
EBIT Q/Q Growth
-10.43% -7.54% 21.93%
NOPAT Q/Q Growth
-10.43% -9.93% 53.61%
Net Income Q/Q Growth
-9.36% -5.92% 22.68%
EPS Q/Q Growth
-13.81% 11.18% 29.55%
Operating Cash Flow Q/Q Growth
-5.63% -2.69% 27.74%
Free Cash Flow Firm Q/Q Growth
-3.84% -3.01% -45.57%
Invested Capital Q/Q Growth
34.01% -12.68% 553.46%
Profitability Metrics
- - -
Gross Margin
74.77% 69.25% 83.37%
EBITDA Margin
-1,211.95% -2,186.73% -70.90%
Operating Margin
-1,245.05% -1,849.01% -33.36%
EBIT Margin
-1,245.05% -2,236.32% -71.18%
Profit (Net Income) Margin
-1,342.70% -2,308.86% -70.92%
Tax Burden Percent
99.92% 100.12% 100.11%
Interest Burden Percent
107.93% 103.12% 99.53%
Effective Tax Rate
0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% -194.43%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% -147.60%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 131.99%
Return on Equity (ROE)
-1,198.36% -961.44% -62.44%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% -198.39%
Operating Return on Assets (OROA)
-132.79% -163.54% -45.97%
Return on Assets (ROA)
-143.21% -168.85% -45.81%
Return on Common Equity (ROCE)
-1,198.36% -961.44% -62.44%
Return on Equity Simple (ROE_SIMPLE)
623.11% -302.20% -38.38%
Net Operating Profit after Tax (NOPAT)
-24 -27 -8.69
NOPAT Margin
-871.54% -1,294.31% -23.35%
Net Nonoperating Expense Percent (NNEP)
-343.69% -226.64% -46.83%
Return On Investment Capital (ROIC_SIMPLE)
- -103.09% -12.64%
Cost of Revenue to Revenue
25.23% 30.75% 16.63%
SG&A Expenses to Revenue
636.37% 1,070.70% 79.43%
R&D to Revenue
683.45% 847.55% 37.29%
Operating Expenses to Revenue
1,319.82% 1,918.26% 116.72%
Earnings before Interest and Taxes (EBIT)
-34 -46 -26
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-33 -45 -26
Valuation Ratios
- - -
Price to Book Value (P/BV)
0.00 5.81 5.60
Price to Tangible Book Value (P/TBV)
0.00 5.81 5.60
Price to Revenue (P/Rev)
11.38 44.41 10.35
Price to Earnings (P/E)
0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 21.38
Enterprise Value to Revenue (EV/Rev)
12.81 33.59 8.92
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00
Leverage & Solvency
- - -
Debt to Equity
-2.68 0.64 0.00
Long-Term Debt to Equity
-1.34 0.00 0.00
Financial Leverage
-1.22 -1.86 -0.89
Leverage Ratio
8.37 5.69 1.36
Compound Leverage Factor
9.03 5.87 1.36
Debt to Total Capital
159.61% 39.15% 0.00%
Short-Term Debt to Total Capital
79.83% 39.15% 0.00%
Long-Term Debt to Total Capital
79.78% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00%
Common Equity to Total Capital
-59.61% 60.85% 100.00%
Debt to EBITDA
-0.48 -0.22 0.00
Net Debt to EBITDA
-0.12 0.50 0.00
Long-Term Debt to EBITDA
-0.24 0.00 0.00
Debt to NOPAT
-0.66 -0.38 0.00
Net Debt to NOPAT
-0.16 0.84 0.00
Long-Term Debt to NOPAT
-0.33 0.00 0.00
Altman Z-Score
-41.08 -19.16 20.14
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00%
Liquidity Ratios
- - -
Current Ratio
1.10 2.26 12.01
Quick Ratio
0.55 1.99 10.44
Cash Flow Metrics
- - -
Free Cash Flow to Firm (FCFF)
-21 -22 -31
Operating Cash Flow to CapEx
-11,937.80% -53,881.03% -3,341.86%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00
Efficiency Ratios
- - -
Asset Turnover
0.11 0.07 0.65
Accounts Receivable Turnover
13.26 6.80 6.68
Inventory Turnover
0.40 0.24 1.21
Fixed Asset Turnover
1.96 1.49 23.68
Accounts Payable Turnover
0.52 0.42 6.27
Days Sales Outstanding (DSO)
27.52 53.65 54.60
Days Inventory Outstanding (DIO)
907.18 1,528.98 302.45
Days Payable Outstanding (DPO)
706.59 870.83 58.19
Cash Conversion Cycle (CCC)
228.11 711.79 298.86
Capital & Investment Metrics
- - -
Invested Capital
-1.99 -6.58 16
Invested Capital Turnover
-3.99 -0.48 8.33
Increase / (Decrease) in Invested Capital
-2.62 -4.58 22
Enterprise Value (EV)
35 69 332
Market Capitalization
31 92 385
Book Value per Share
($0.68) $0.72 $2.15
Tangible Book Value per Share
($0.68) $0.72 $2.15
Total Capital
9.83 26 69
Total Debt
16 10 0.00
Total Long-Term Debt
7.84 0.00 0.00
Net Debt
3.87 -22 -53
Capital Expenditures (CapEx)
0.21 0.06 0.56
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-2.56 -1.64 14
Debt-free Net Working Capital (DFNWC)
9.27 31 68
Net Working Capital (NWC)
1.42 21 68
Net Nonoperating Expense (NNE)
13 21 18
Net Nonoperating Obligations (NNO)
3.87 -22 -53
Total Depreciation and Amortization (D&A)
0.90 1.02 0.10
Debt-free, Cash-free Net Working Capital to Revenue
-94.01% -79.61% 38.66%
Debt-free Net Working Capital to Revenue
340.79% 1,494.43% 181.74%
Net Working Capital to Revenue
52.23% 1,002.91% 181.74%
Earnings Adjustments
- - -
Adjusted Basic Earnings per Share
($4.12) ($2.94) ($0.93)
Adjusted Weighted Average Basic Shares Outstanding
8.86M 16.23M 28.51M
Adjusted Diluted Earnings per Share
($4.12) ($2.94) ($0.93)
Adjusted Weighted Average Diluted Shares Outstanding
8.86M 16.23M 28.51M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
10.06M 24.56M 33.40M
Normalized Net Operating Profit after Tax (NOPAT)
-24 -27 -8.69
Normalized NOPAT Margin
-871.54% -1,294.31% -23.35%
Pre Tax Income Margin
-1,343.80% -2,306.00% -70.84%
Debt Service Ratios
- - -
EBIT to Interest Expense
0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00
Payout Ratios
- - -
Dividend Payout Ratio
0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Delcath Systems

This table displays calculated financial ratios and metrics derived from Delcath Systems' official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
73.56% -69.75% 57.94% -37.89% -52.10% -15.52% 425.80% 1,468.89% 2,480.65% 2,701.48%
EBITDA Growth
-15.94% -79.46% -0.85% 29.62% -160.37% -34.88% -33.67% -105.59% 108.58% 66.02%
EBIT Growth
-22.06% -68.33% 0.36% 27.93% -143.97% -41.32% -30.81% -99.90% 108.61% 67.14%
NOPAT Growth
-22.06% -68.65% 0.18% 15.70% -29.16% -43.93% -23.46% 51.08% 82.96% 126.88%
Net Income Growth
-24.59% -58.44% 0.00% 29.11% -129.13% -31.44% -23.46% -90.79% 109.16% 69.49%
EPS Growth
-2.13% -9.33% 30.00% 53.23% -18.75% 45.12% 41.56% 17.24% 105.26% 86.67%
Operating Cash Flow Growth
-5.56% -22.06% 33.11% -59.81% -76.89% -11.13% -124.77% 53.87% 60.27% 87.70%
Free Cash Flow Firm Growth
47.26% 66.46% 137.55% 77.91% -0.38% -15.83% -375.26% 300.05% 19.62% -499.70%
Invested Capital Growth
-62.89% -415.85% -1,774.73% -330.03% -93.28% -230.01% 44.83% -121.36% 41.39% 335.87%
Revenue Q/Q Growth
13.68% -29.58% -6.43% -17.09% -12.32% 24.19% 482.37% 147.40% 44.22% 34.82%
EBITDA Q/Q Growth
19.41% -4.98% -1.90% 18.36% -198.13% 45.62% 1.50% -25.57% 112.44% -315.37%
EBIT Q/Q Growth
13.84% 4.09% -6.20% 17.87% -191.65% 44.44% 1.70% -25.50% 112.56% -312.12%
NOPAT Q/Q Growth
13.84% 3.90% -6.00% 3.94% -32.00% -7.09% 9.08% 61.94% 54.02% 268.97%
Net Income Q/Q Growth
12.62% 4.56% -6.23% 19.98% -182.42% 45.25% 0.22% -23.67% 113.57% -282.30%
EPS Q/Q Growth
22.58% 14.58% 6.10% 24.68% -96.55% 60.53% 0.00% -6.67% 112.50% -200.00%
Operating Cash Flow Q/Q Growth
14.21% -42.09% 42.06% -126.27% 5.05% 10.73% -17.19% 53.56% 18.22% 72.36%
Free Cash Flow Firm Q/Q Growth
41.05% 36.91% 244.29% -141.16% -167.87% 27.19% -242.87% 129.92% -207.63% -443.20%
Invested Capital Q/Q Growth
-156.15% 34.01% -372.25% 46.13% -15.13% -12.68% 21.04% -116.12% 69.52% 553.46%
Profitability Metrics
- - - - - - - - - -
Gross Margin
74.06% 62.70% 69.68% 69.70% 69.35% 68.27% 71.23% 80.44% 85.36% 85.92%
EBITDA Margin
-835.87% -1,246.08% -1,356.95% -1,336.16% -4,543.32% -1,989.42% -344.98% -175.10% 15.11% -24.13%
Operating Margin
-902.10% -1,231.03% -1,394.47% -1,615.56% -2,432.26% -2,097.22% -327.43% -50.37% -11.24% 20.13%
EBIT Margin
-902.10% -1,228.68% -1,394.47% -1,381.21% -4,594.47% -2,055.29% -346.93% -175.99% 15.32% -24.11%
Profit (Net Income) Margin
-979.80% -1,327.90% -1,507.54% -1,454.95% -4,686.64% -2,066.05% -353.97% -176.94% 16.64% -22.50%
Tax Burden Percent
99.71% 99.86% 99.86% 99.92% 100.02% 100.66% 100.20% 99.93% 101.91% 101.58%
Interest Burden Percent
108.93% 108.23% 108.26% 105.43% 101.98% 99.86% 101.83% 100.61% 106.59% 91.90%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 117.31%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 131.93%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -117.98%
Return on Equity (ROE)
-1,030.34% -1,198.36% -694.27% 2,172.99% -462.32% -961.44% -500.09% -2,852.05% -205.01% -0.67%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -198.39%
Operating Return on Assets (OROA)
-138.32% -131.05% -141.48% -172.90% -293.27% -150.30% -47.93% -76.06% 8.75% -15.57%
Return on Assets (ROA)
-150.24% -141.63% -152.95% -182.13% -299.16% -151.09% -48.90% -76.48% 9.51% -14.54%
Return on Common Equity (ROCE)
-1,030.34% -1,198.36% 518.27% 2,172.99% -462.32% -961.44% -38.78% -2,852.05% -205.01% -0.67%
Return on Equity Simple (ROE_SIMPLE)
636.35% 0.00% 279.20% 0.00% -182.10% 0.00% -340.55% -1,343.70% -398.13% 0.00%
Net Operating Profit after Tax (NOPAT)
-5.72 -5.50 -5.83 -5.60 -7.39 -7.91 -7.19 -2.74 -1.26 2.13
NOPAT Margin
-631.47% -861.72% -976.13% -1,130.89% -1,702.58% -1,468.05% -229.20% -35.26% -11.24% 14.09%
Net Nonoperating Expense Percent (NNEP)
-55.59% -79.79% -32.76% -101.49% -91.43% -34.87% -22.69% -108.71% 14.68% -14.62%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - -30.52% - - - 3.09%
Cost of Revenue to Revenue
25.94% 37.30% 30.32% 30.30% 30.65% 31.73% 28.77% 19.56% 14.64% 14.08%
SG&A Expenses to Revenue
527.48% 599.22% 697.65% 967.07% 1,427.42% 1,291.84% 280.79% 87.11% 62.08% 46.50%
R&D to Revenue
448.68% 694.51% 766.50% 718.18% 1,074.19% 873.65% 117.87% 43.70% 34.52% 19.30%
Operating Expenses to Revenue
976.16% 1,293.73% 1,464.15% 1,685.25% 2,501.61% 2,165.49% 398.66% 130.81% 96.60% 65.79%
Earnings before Interest and Taxes (EBIT)
-8.17 -7.84 -8.33 -6.84 -20 -11 -11 -14 1.72 -3.64
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-7.57 -7.95 -8.10 -6.61 -20 -11 -11 -14 1.69 -3.64
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 0.00 2.50 5.81 8.01 55.48 29.50 5.60
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 2.50 5.81 8.01 55.48 29.50 5.60
Price to Revenue (P/Rev)
6.57 11.38 19.69 23.49 28.59 44.41 25.43 19.58 11.17 10.35
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 21.38
Enterprise Value to Revenue (EV/Rev)
7.10 12.81 20.94 21.66 14.47 33.59 21.13 18.28 10.64 8.92
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
-3.09 -2.68 1.81 -40.34 0.40 0.64 0.50 1.07 0.23 0.00
Long-Term Debt to Equity
-1.85 -1.34 1.10 -21.70 0.08 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-1.75 -1.22 -1.84 1.02 -1.45 -1.86 -1.73 -5.12 -1.28 -0.89
Leverage Ratio
8.43 8.37 5.51 -13.64 3.48 5.69 3.35 13.91 2.38 1.36
Compound Leverage Factor
9.19 9.06 5.96 -14.38 3.55 5.69 3.41 14.00 2.54 1.25
Debt to Total Capital
147.86% 159.61% 64.39% 102.54% 28.71% 39.15% 33.48% 51.72% 18.92% 0.00%
Short-Term Debt to Total Capital
59.12% 79.83% 25.37% 47.37% 22.94% 39.15% 33.48% 51.72% 18.92% 0.00%
Long-Term Debt to Total Capital
88.73% 79.78% 39.02% 55.17% 5.77% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 123.61% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
-47.86% -59.61% -87.99% -2.54% 71.29% 60.85% 66.52% 48.28% 81.08% 100.00%
Debt to EBITDA
-0.55 -0.48 -0.29 -0.32 -0.23 -0.22 -0.15 -0.08 -0.06 0.00
Net Debt to EBITDA
-0.08 -0.12 0.45 0.16 0.72 0.50 0.41 0.28 0.36 0.00
Long-Term Debt to EBITDA
-0.33 -0.24 -0.18 -0.17 -0.05 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
-0.76 -0.66 -0.40 -0.43 -0.41 -0.38 -0.26 -0.18 -0.11 0.00
Net Debt to NOPAT
-0.10 -0.16 0.62 0.21 1.26 0.84 0.71 0.61 0.64 0.00
Long-Term Debt to NOPAT
-0.45 -0.33 -0.24 -0.23 -0.08 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
-31.20 -36.27 -20.16 -30.23 -13.44 -16.16 -16.94 -17.49 -15.61 21.12
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 174.65% 0.00% 0.00% 0.00% 92.25% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
1.28 1.10 2.16 1.75 3.30 2.26 2.52 2.55 1.34 12.01
Quick Ratio
0.72 0.55 1.84 1.32 2.91 1.99 2.15 1.92 0.97 10.44
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-4.56 -2.87 4.15 -1.71 -4.57 -3.33 -11 3.41 -3.68 -20
Operating Cash Flow to CapEx
-7,616.18% 0.00% 0.00% -24,120.00% 0.00% -43,042.11% -73,723.08% -4,406.93% -1,685.19% -439.30%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.15 0.11 0.10 0.13 0.06 0.07 0.14 0.43 0.57 0.65
Accounts Receivable Turnover
13.83 13.26 9.24 9.33 5.83 6.80 4.56 6.17 6.34 6.68
Inventory Turnover
0.37 0.40 0.38 0.36 0.31 0.24 0.45 0.62 0.91 1.21
Fixed Asset Turnover
2.96 1.96 2.10 1.84 1.53 1.49 3.38 8.41 14.59 23.68
Accounts Payable Turnover
0.30 0.52 0.45 0.53 0.41 0.42 0.69 1.28 5.01 6.27
Days Sales Outstanding (DSO)
26.40 27.52 39.51 39.12 62.58 53.65 80.10 59.20 57.55 54.60
Days Inventory Outstanding (DIO)
999.01 907.18 951.45 1,026.00 1,194.05 1,528.98 803.03 588.87 401.34 302.45
Days Payable Outstanding (DPO)
1,205.83 706.59 803.31 688.46 880.00 870.83 526.52 284.19 72.86 58.19
Cash Conversion Cycle (CCC)
-180.42 228.11 187.65 376.65 376.62 711.79 356.61 363.88 386.04 298.86
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
-3.02 -1.99 -9.41 -5.07 -5.84 -6.58 -5.19 -11 -3.42 16
Invested Capital Turnover
-1.72 -3.99 -0.66 -0.84 -0.49 -0.48 -0.63 -1.46 -4.89 8.33
Increase / (Decrease) in Invested Capital
-1.17 -2.62 -9.97 -3.89 -2.82 -4.58 4.22 -6.15 2.42 22
Enterprise Value (EV)
30 35 62 57 31 69 97 217 241 332
Market Capitalization
28 31 58 62 62 92 117 233 253 385
Book Value per Share
($0.61) ($0.68) ($1.30) ($0.02) $1.62 $0.72 $0.60 $0.15 $0.31 $2.15
Tangible Book Value per Share
($0.61) ($0.68) ($1.30) ($0.02) $1.62 $0.72 $0.60 $0.15 $0.31 $2.15
Total Capital
11 9.83 15 9.52 35 26 22 8.68 11 69
Total Debt
16 16 9.57 9.76 9.96 10 7.36 4.49 2.00 0.00
Total Long-Term Debt
9.73 7.84 5.80 5.25 2.00 0.00 0.00 0.00 0.00 0.00
Net Debt
2.23 3.87 -15 -4.83 -31 -22 -20 -15 -12 -53
Capital Expenditures (CapEx)
0.07 0.00 0.00 0.04 -0.00 0.02 0.01 0.10 0.22 0.23
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-3.47 -2.56 -4.89 -1.72 -0.43 -1.64 0.49 3.69 -4.69 14
Debt-free Net Working Capital (DFNWC)
11 9.27 19 13 40 31 28 24 9.30 68
Net Working Capital (NWC)
4.03 1.42 16 8.36 32 21 20 19 7.30 68
Net Nonoperating Expense (NNE)
3.16 2.97 3.17 1.60 13 3.22 3.92 11 -3.12 5.53
Net Nonoperating Obligations (NNO)
2.23 3.87 -15 -4.83 -31 -22 -20 -15 -12 -53
Total Depreciation and Amortization (D&A)
0.60 -0.11 0.22 0.22 0.22 0.36 0.06 0.07 -0.02 -0.00
Debt-free, Cash-free Net Working Capital to Revenue
-82.74% -94.01% -166.47% -65.33% -20.06% -79.61% 10.68% 31.09% -20.73% 38.66%
Debt-free Net Working Capital to Revenue
250.95% 340.79% 659.67% 488.16% 1,852.03% 1,494.43% 600.43% 198.68% 41.06% 181.74%
Net Working Capital to Revenue
96.28% 52.23% 531.35% 317.07% 1,484.38% 1,002.91% 440.74% 160.87% 32.23% 181.74%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
($0.92) ($0.82) ($0.77) ($0.58) ($1.14) ($0.45) ($0.45) ($0.48) $0.06 ($0.06)
Adjusted Weighted Average Basic Shares Outstanding
9.22M 8.86M 11.62M 12.46M 17.86M 16.23M 24.89M 28.36M 28.74M 28.51M
Adjusted Diluted Earnings per Share
($0.92) ($0.82) ($0.77) ($0.58) ($1.14) ($0.45) ($0.45) ($0.48) $0.06 ($0.06)
Adjusted Weighted Average Diluted Shares Outstanding
9.22M 8.86M 11.62M 12.46M 17.86M 16.23M 24.89M 28.36M 32.35M 28.51M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
8.60M 10.06M 10.62M 15.28M 22.05M 24.56M 27.79M 28.00M 31.97M 33.40M
Normalized Net Operating Profit after Tax (NOPAT)
-5.72 -5.50 -5.83 -5.60 -7.39 -7.91 -7.19 -2.74 -0.88 2.13
Normalized NOPAT Margin
-631.47% -861.72% -976.13% -1,130.89% -1,702.58% -1,468.05% -229.20% -35.26% -7.87% 14.09%
Pre Tax Income Margin
-982.67% -1,329.78% -1,509.72% -1,456.16% -4,685.48% -2,052.50% -353.27% -177.07% 16.33% -22.15%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Delcath Systems (NASDAQ: DCTH) showed strong top-line growth in Q4 2024, but profitability and cash burn remain key concerns. Revenue jumped sharply year over year, and the company generated a large inflow from financing activities during the quarter. However, Delcath still posted a net loss and negative operating cash flow, which suggests the business is still in an investment-heavy phase.

  • Revenue growth accelerated sharply in Q4 2024. Quarterly revenue rose to $15.1 million from $11.2 million in Q3 2024 and just $539,000 in Q4 2023, showing major commercial momentum.
  • Gross profit improved significantly. Q4 2024 gross profit was $12.97 million, with gross margin around 85.8%, indicating a favorable product economics profile.
  • Operating income turned positive. The company reported $3.0 million in operating income in Q4 2024, compared with an operating loss in prior periods.
  • Cash position improved materially during the quarter. Net cash increased by $24.1 million in Q4 2024, helped by $42.4 million in other financing activities.
  • Balance sheet liquidity improved from midyear levels. Cash and equivalents plus short-term investments increased meaningfully versus Q3 2024, giving the company more runway.
  • Operating cash flow was still negative. Q4 2024 operating cash flow was -$1.0 million, and full-quarter continuing operating cash flow was -$0.9 million, so the company is not yet self-funding.
  • Net income remained negative. Despite operating improvement, Delcath still posted a net loss of $3.4 million in Q4 2024.
  • SG&A and R&D spending remain elevated. Q4 2024 SG&A was $7.0 million and R&D was $2.9 million, which supports growth but also weighs on earnings.
  • Other expense was a major drag on profitability. Delcath recorded $6.7 million in other income/expense, net as an expense in Q4 2024, which pushed pretax results back into the red.
  • The company remains dependent on financing. Over the last several quarters, Delcath has repeatedly relied on equity and other financing sources to support operations and debt repayment.

Longer-term trend: Delcath has made clear progress in revenue generation since early 2023, when quarterly sales were only in the low hundreds of thousands. By 2024, revenue was consistently much higher, and Q4 showed the strongest operating performance in the period reviewed. Still, the company has not yet established durable profitability or positive operating cash flow, so execution and cash runway will remain important for investors.

Bottom line: Delcath’s operating trend is improving fast, but the stock still carries the risks of a turnaround story: losses, financing dependence, and cash burn. The Q4 2024 report is encouraging on growth and margins, but investors will likely want to see sustained profitability before calling the business fully stabilized.

06/03/26 10:23 AM ETAI Generated. May Contain Errors.

Delcath Systems Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Delcath Systems' fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

Delcath Systems' net income appears to be on a downward trend, with a most recent value of -$26.39 million in 2024, falling from -$36.51 million in 2022. The previous period was -$47.68 million in 2023. See where experts think Delcath Systems is headed by visiting Delcath Systems' forecast page.

Delcath Systems' total operating income in 2024 was -$12.41 million, based on the following breakdown:
  • Total Gross Profit: $31.02 million
  • Total Operating Expenses: $43.43 million

Over the last 2 years, Delcath Systems' total revenue changed from $2.72 million in 2022 to $37.21 million in 2024, a change of 1,268.3%.

Delcath Systems' total liabilities were at $7.84 million at the end of 2024, a 65.7% decrease from 2023, and a 66.9% decrease since 2022.

In the past 2 years, Delcath Systems' cash and equivalents has ranged from $7.67 million in 2022 to $32.41 million in 2024, and is currently $32.41 million as of their latest financial filing in 2024.

Over the last 2 years, Delcath Systems' book value per share changed from -0.68 in 2022 to 2.15 in 2024, a change of -415.5%.



Financial statements for NASDAQ:DCTH last updated on 4/6/2025 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners